aminoglutethimide has been researched along with Leukemia, Myeloid, Acute in 13 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Excerpt | Relevance | Reference |
---|---|---|
"In 74% of the acute myeloid leukemia patients, the truncated inhibitor was detected." | 1.29 | Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. ( Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A, 1995) |
"The position of each ANLL was determined on the basis of the peroxidase and nonspecific esterase reactivity of the blast cells." | 1.28 | Cytochemical maturation index for the prognostication of adult acute nonlymphocytic leukaemia. ( Fekete, S; Gráf, F; Raposa, T; Várkonyi, J, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krug, U | 1 |
Berdel, WE | 1 |
Gale, RP | 1 |
Haferlach, C | 2 |
Schnittger, S | 2 |
Müller-Tidow, C | 1 |
Braess, J | 1 |
Spiekermann, K | 1 |
Staib, P | 2 |
Beelen, D | 1 |
Serve, H | 1 |
Schliemann, C | 1 |
Stelljes, M | 1 |
Balleisen, L | 2 |
Maschmeyer, G | 1 |
Grüneisen, A | 1 |
Eimermacher, H | 1 |
Giagounidis, A | 1 |
Rasche, H | 1 |
Hehlmann, R | 1 |
Lengfelder, E | 1 |
Thiel, E | 1 |
Reichle, A | 1 |
Aul, C | 1 |
Ludwig, WD | 1 |
Kern, W | 1 |
Haferlach, T | 2 |
Köpcke, W | 1 |
Görlich, D | 1 |
Sauerland, MC | 1 |
Heinecke, A | 1 |
Wörmann, BJ | 1 |
Hiddemann, W | 6 |
Büchner, T | 5 |
Goetz, M | 1 |
Schiel, X | 1 |
Heussel, H | 1 |
Steinmetz, T | 1 |
Weiss, M | 1 |
Weisser, M | 1 |
Dengler, R | 1 |
Plewan, A | 1 |
Münstermann, U | 1 |
Busch, R | 1 |
Eger, G | 1 |
Emmerich, B | 1 |
Lathan, B | 1 |
Schinköthe, T | 1 |
Wiedenmann, S | 1 |
Pantke, B | 1 |
Dimski, T | 1 |
Voliotis, D | 1 |
Diehl, V | 1 |
Zühlsdorf, M | 1 |
Wörmann, B | 2 |
Koenigsmann, M | 1 |
Raposa, T | 1 |
Várkonyi, J | 1 |
Fekete, S | 1 |
Gráf, F | 1 |
Stein, RS | 1 |
Volkenandt, M | 1 |
Van de Loo, J | 1 |
Göhde, W | 1 |
Lutz, D | 2 |
Grisold, W | 1 |
Mokrusa, W | 1 |
Mamoli, B | 1 |
Weber, R | 1 |
Achterrath, W | 1 |
Urbanitz, D | 1 |
Preusser, P | 1 |
1 review available for aminoglutethimide and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Advances in the therapy of acute nonlymphocytic leukemia.
Topics: Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; H | 1989 |
3 trials available for aminoglutethimide and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Disea | 2016 |
Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Topics: Adult; Aged; Aminoglutethimide; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Danazo | 2002 |
Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bla | 1999 |
9 other studies available for aminoglutethimide and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy | 2007 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; | 1995 |
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Stimula | 1990 |
Cytochemical maturation index for the prognostication of adult acute nonlymphocytic leukaemia.
Topics: Adult; Age Factors; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; C | 1989 |
Acute leukaemia during pregnancy.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Danazol; Female; Humans; I | 1987 |
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes.
Topics: Adolescent; Adult; Age Factors; Aged; Aminoglutethimide; Aneuploidy; Antineoplastic Combined Chemoth | 1986 |
[Various induction therapies in older patients with acute myeloid leukemias].
Topics: Aclarubicin; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protoc | 1985 |
[Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms].
Topics: Abducens Nerve; Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 1985 |
[AMSA/etoposide (VP 16-213). A phase I/II study in refractory acute myeloid leukemia].
Topics: Aminoacridines; Aminoglutethimide; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemoth | 1985 |